This opportunity is no longer accepting applications.
grant RFA-DA-24-038

Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)

This grant opportunity is for small businesses looking to research and commercialize innovative, FDA-regulated medical products for opioid and stimulant use disorders. The focus is on two scientific areas: pharmacotherapeutics (like small molecules and biologics) and medical diagnostic or therapeutic devices, including software. The goal is to aid in addressing the national opioid and psychost…

This Notice of Funding Opportunity (NOFO) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) proposing research projects directed towards commercialization for the development of novel, evidence-based, FDA-regulated medical products addres…

Funding Source

Agency: National Institutes of Health
Program: STTR
Phase: Phase II
Phase: Phase I

Awards & funding

Award Ceiling: $300,000
Award Amount: $300,000

Dates

Opportunity Released: April 18, 2023
Open for Submission: April 18, 2023
Submission Deadline: February 14, 2025
Application Window Closes: February 14, 2025

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.